|
Vidal-Sanz M, Galindo-Romero C, Valiente-Soriano FJ, Nadal-Nicolás FM, Ortin-Martinez A, Rovere G, Salinas-Navarro M, Lucas-Ruiz F, Sanchez-Migallon MC, Sobrado-Calvo P, Aviles-Trigueros M, Villegas-Pérez MP, Agudo-Barriuso M. Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension. Front Neurosci. 2017 Apr 26;11:235. doi: 10.3389/fnins.2017.00235. eCollection 2017. Review. PubMed PMID: 28491019; PubMed Central PMCID: PMC5405145.
AÑO: 2017; IF: 3.877
|
28491019
|
Galindo-Romero C., Harun-Or-Rashid M., Jiménez-López M., Vidal-Sanz M., Agudo-Barriuso M., Hallböök F. Neuroprotection by α2-adrenergic receptor stimulation after excitotoxic retinal injury: A study of the totalpopulation of retinal ganglion cells and their distribution in the chicken retina. PLoS ONE. September 2016. 11. 10.1371/journal.pone.0161862
AÑO: 2016; IF: 2.806
|
|
Madeira M.H., Ortin-Martinez A., Nadal-Nícolas F., Ambrósio A.F., Vidal-Sanz M., Agudo-Barriuso M., Santiago A.R. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Scientific Reports. 8 June 2016. 6. 10.1038/srep27532
AÑO: 2016; IF: 4.259
|
|
Nadal-Nicolás FM, Galindo-Romero C, Valiente-Soriano FJ, Barberà-Cremades M, deTorre-Minguela C, Salinas-Navarro M, Pelegrín P, Agudo-Barriuso M. Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury. Sci Rep. 2016 Dec 8;6:38499. doi: 10.1038/srep38499. PubMed PMID: 27929040; PubMed Central PMCID: PMC5144087.
AÑO: 2016; IF: 4.259
|
|
Nadal-Nicolás F.M., Rodriguez-Villagra E., Bravo-Osuna I., Sobrado-Calvo P., Molina-Martínez I., Villegas-Pérez M.P., Vidal-Sanz M., Agudo-Barriuso M., Herrero-Vanrell R. Ketorolac administration attenuates retinal ganglion cell death after axonal injury. Investigative Ophthalmology and Visual Science. 1 March 2016. 57:1183-1192. 10.1167/iovs.15-18213
AÑO: 2016; IF: 3.303
|